Interview with Wei Wang
How are safety analyses different from efficacy analyses?
What does validation and quality control mean for interactive visualization?
Over recent years, a lot of interesting things happened around safety analyses and visualization. They help us to better understand our safety data and detect safety signals. Wei and colleagues have recently published an article about these topics.
In today’s episode, Wei and I dive deep into the future of safety analyses and discuss the following topics:[Read more…] about The future of safety analyses: interactivity, visualizations and the FDA